Searched for
ZYDUS WORLDWIDE DMCC
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisitionZydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Stocks in the news: Landmark Cars, RIL, Abans Holdings, Yes Bank, Wipro and Dronacharya AerialDalal Street will witness the debut of three company on Friday, December 23, 2022 including mainboard companies- Landmark Cars, and Abans H...
- Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...
- Stocks in the news: HUL, IndusInd Bank, M&M, Yes Bank, Coal India and NTPCHUL, HDFC Life, Ambuja Cement, ICICI Lombard GIC, AU Bank, Polycab, Hatsun Agro, L&T Finance, DCM Shriram and Rallis India are among the co...
- Zydus gets USFDA nod to market generic antifungal medicationEfinaconazole is an antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton ...
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Zydus Healthcare buys 2 ANDAs from TevaThe company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group...
Load More
